Whats new
Whats new.
goetzpartners securities - First in class opening the cancer immune throttle
May 14th 2020
This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.